ResMed Inc (RMD) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software.
Total Assets Chart for ResMed Inc
ResMed Inc (RMD) total assets for FY2026 were USD 9.0B, a 9.7% change from FY2025. ResMed Inc's total assets grew from USD 5.2M in 1993 to USD 9.0B in 2026 (172322.1% over 33 years). Total assets compound annual growth rate: 5-year CAGR of 13.7%, 10-year CAGR of 10.7%, 20-year CAGR of 11.6%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $32.38B
- Implied Share Price
- $224.46
- Enterprise Value
- $31.74B
- Revenue (TTM)
- $5.65B
- EBITDA
- $2.10B
- Profit Margin
- 26.95%
- Trailing P/E
- 21.50
- Forward P/E
- 18.69
- Price/Book (MRQ)
- 4.92
- Price/Sales (TTM)
- 5.73
- EV/EBITDA
- 14.74
- EV/Revenue
- 5.61
- Dividend Yield
- 1.06%
- Book Value
- $45.51
- Free Cash Flow (FY2026)
- $1.65B
- Free Cash Flow Yield
- 5.09%
Snapshot as of 16th August 2026 — not point-in-time controlled, may lag the live market by a few days.